NLRP3 and hepatocellular carcinoma: The relevant studies have reported that NLRP3 inflammasome upregulates the expression of PD-L1 in patients with diffuse large B-cell lymphoma (Lu et al., 2021), and IRF1 promoted the expression of PD-L1 in hepatoma cells (Xiao et al., 2019).